Mild Encephalopathy with Reversible Splenic Lesions in an Infant with COVID-19

Authors

  • Natsuki Yagi Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
  • Ryo Sugitate Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
  • Mariko Shimizu Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
  • Tomomi Ogata Department of Paediatrics, Gunma University Graduate School of Medicine, Chome - 39-22 Showamachi, Maebashi, Gunma 371-0034, Japan

Abstract

There have been few reports of mild encephalopathy with reversible splenic lesions (MERS) associated with COVID-19 in infants. Here, we present a case of MERS in a 23-month-old infant with COVID-19 in Japan during the Omicron variant epidemic. The increase in COVID-19 acute encephalopathy in infants, including those with MERS, should be considered in the future due to the prevalence of the Omicron variant strain. Meanwhile, whether the cause is COVID-19, acute encephalopathy with a lesion localized in the splenium of the corpus callosum can be treated with temporary anticonvulsant therapy, as is generally the case with MERS.

Abstract
106
PDF
0

Downloads

Published

2023-09-10

How to Cite

Mild Encephalopathy with Reversible Splenic Lesions in an Infant with COVID-19 . (2023). Journal of Nepal Paediatric Society, 43(1), 105-107. https://doi.org/10.60086/jnps498

Issue

Vol. 43 No. 1 (2023)

Section

Brief Reports/Case Reports/Case Series

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

Mild Encephalopathy with Reversible Splenic Lesions in an Infant with COVID-19 . (2023). Journal of Nepal Paediatric Society, 43(1), 105-107. https://doi.org/10.60086/jnps498